Stockscreener 앱 받기
18.37
8.38%
1.42
시장 영업 전:
18.37
전일 마감가:
$16.95
열려 있는:
$17.02
하루 거래량:
241.21K
Relative Volume:
1.03
시가총액:
$506.73M
수익:
$30.43M
순이익/손실:
$-18.15M
주가수익비율:
-26.62
EPS:
-0.69
순현금흐름:
$-9.08M
1주 성능:
+2.40%
1개월 성능:
+15.61%
6개월 성능:
+163.94%
1년 성능:
+156.92%
1일 변동 폭
$16.99
$18.50
1주일 범위
$16.27
$18.50
52주 변동 폭
$5.105
$19.00
Clearpoint Neuro Inc Stock (CLPT) Company Profile
명칭
Clearpoint Neuro Inc
전화
(949) 900-6833
주소
120 S. SIERRA AVENUE, SOLANA BEACH, CA
CLPT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
18.37 | 506.73M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
129.10 | 223.92B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
103.54 | 152.60B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
392.39 | 149.59B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.97 | 116.65B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.33 | 42.07B | 6.60B | 4.16B | 490.10M | 6.93 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-25 | 재개 | B. Riley Securities | Buy |
| 2023-10-24 | 개시 | Stifel | Buy |
| 2023-02-16 | 재개 | B. Riley Securities | Buy |
| 2022-04-05 | 재개 | B. Riley Securities | Buy |
| 2021-03-18 | 개시 | Lake Street | Buy |
| 2020-07-17 | 개시 | B. Riley FBR | Buy |
모두보기
Clearpoint Neuro Inc 주식(CLPT)의 최신 뉴스
JPMorgan Chase & Co. Has $110,000 Holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
B. Riley Boosts ClearPoint Neuro (NASDAQ:CLPT) Price Target to $20.00 - MarketBeat
Stifel maintains Clearpoint Neuro stock Buy rating, $17 target - MSN
B. Riley Raises ClearPoint Neuro (NASDAQ:CLPT) Price Target to $20.00 - Defense World
How to Take Advantage of moves in (CLPT) - Stock Traders Daily
Stifel maintains Clearpoint Neuro stock Buy rating, $17 target By Investing.com - Investing.com UK
ClearPoint Neuro price target raised to $20 from $15 at B. Riley - Yahoo Finance
ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory - Insider Monkey
B. Riley Raises Price Target on ClearPoint Neuro to $20 From $15, Keeps Buy Rating - Marketscreener.com
CLPT Stock Gains on FDA Clearance for Navigation Software Version 3.0 - Yahoo Finance
ClearPoint Neuro gains FDA clearance for software - MSN
ClearPoint Neuro Secures FDA Clearance for Revolutionary CT Navigation Software - StockTitan
Barclays PLC Raises Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Conway Capital Management Inc. Boosts Stock Holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
ClearPoint Neuro (CLPT) Surges 22.5%: Is This an Indication of Further Gains? - MSN
CLPT Stock Touches 52-Week High at $17.49 Amidst Strong Yearly Growth - MSN
Lake Street Capital Issues Positive Forecast for ClearPoint Neuro (NASDAQ:CLPT) Stock Price - Defense World
ClearPoint Neuro (NASDAQ:CLPT) Sets New 12-Month High After Analyst Upgrade - Defense World
Clearpoint Neuro stock target lifted, buy rating on robust performance By Investing.com - Investing.com Canada
ClearPoint Neuro Reports Third Quarter 2024 Results - ACCESS Newswire
ClearPoint Neuro (NASDAQ:CLPT) Reaches New 1-Year High on Analyst Upgrade - MarketBeat
Clearpoint Neuro stock target lifted, buy rating on robust performance - MSN
Barclays PLC Boosts Stock Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Trend Tracker for (CLPT) - Stock Traders Daily
Geode Capital Management LLC Buys 4,170 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Here's What Could Help ClearPoint Neuro (CLPT) Maintain Its Recent Price Strength - MSN
State Street Corp Has $1.18 Million Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Jane Street Group LLC Has $1.14 Million Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Sold by Jane Street Group LLC - MarketBeat
Long Term Trading Analysis for (CLPT) - Stock Traders Daily
OU Health adds technology for deep brain stimulation procedures - Norman Transcript
Conway Capital Management Inc. Takes Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
After Leaping 26% ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Are Not Flying Under The Radar - Simply Wall St
ClearPoint: Fundamentals Continue To Improve (NASDAQ:CLPT) - Seeking Alpha
(CLPT) Proactive Strategies - Stock Traders Daily
(CLPT) Technical Pivots with Risk Controls - Stock Traders Daily
ClearPoint Neuro Inc (CLPT) Trading 3.92% Higher on Oct 9 - GuruFocus.com
Pekin Hardy Strauss Inc. Invests $541,000 in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
Oppenheimer & Co. Inc. Takes Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
West Pharmaceutical Services (NYSE:WST) & ClearPoint Neuro (NASDAQ:CLPT) Critical Comparison - Defense World
Global MRI Guided Neurosurgical Ablation Market Poised for Steady Growth, Projected to Reach USD 227.56 Million by 2034 Driven by Growing Adoption and Advancements in Non-Cooled Laser Systems: FMI - GlobeNewswire Inc.
(CLPT) Investment Analysis - Stock Traders Daily
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain - AccessWire
ClearPoint Neuro Inc (CLPT) Trading 6.12% Higher on Nov 14 - GuruFocus.com
ClearPoint (CLPT) Gains An FDA Approval, Driving Market Interest - Stocks Telegraph
Clearpoint Neuro Inc (CLPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.33%
0.49%
자본화:
|
볼륨(24시간):